Humana (HUM) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
24 Oct, 2025Executive summary
Achieved all-time high operating profit of SEK 206m and margin at 8.3% in Q3 2025, with a 32% year-over-year increase in earnings per share, driven by efficiency gains, reduced financing costs, and a completed turnaround in Finland.
Tripled growth pipeline in targeted areas, supporting confidence in future growth strategy and industry leadership in sustainability.
Received SBTi validation for climate targets, first among peers to set both short- and long-term net zero targets by 2050.
Efficiency and consolidation programs delivered SEK 40m in annual effects year-to-date, targeting SEK 100m by end of 2026.
Net profit after tax for Q3 was SEK 120m, up 27% year-over-year.
Financial highlights
Q3 net revenue: SEK 10,215m (up 2% year-over-year); Q3 operating profit: SEK 206m (up 6%); operating margin: 8.3% (up from 7.3%).
Free cash flow for the last twelve months was SEK 186m, with significant utilization for dividends and share buybacks; Q3 free cash flow was SEK -17m due to SEK 307m loan repayment.
SEK 18m one-off investment subsidy received, positively impacting cash flow.
SEK 40m in cost savings already executed, with SEK 10m net benefit realized in Q3.
Adjusted operating margin LTM stable at 4.6%.
Outlook and guidance
Focus on securing organic growth by signing more projects and filling unused capacity, with continued digitalization and AI implementation to drive efficiency.
Personal assistance segment expected to face challenges in Q4 and maintain current profitability levels in 2026 due to limited allowance fee increase, with improvement postponed to 2027.
Norwegian margin run rate expected to be above 6%, with continued improvement; Finland run rate at 6.5% with further increases anticipated.
New loan agreement expected to reduce annual net interest by SEK 35m.
Growth-oriented organization moving forward, especially in disability services.
Latest events from Humana
- EPS up 65% to SEK 4.73; new projects, acquisitions, and higher dividend offset revenue decline.HUM
Q4 20256 Feb 2026 - Adjusted operating profit up 40% to SEK 107m, with 5% revenue growth and higher leverage.HUM
Q2 20243 Feb 2026 - Record Q3 profit and 11% revenue growth driven by acquisitions and operational improvements.HUM
Q3 202419 Jan 2026 - Revenue up 7% to SEK 10.3bn, margin at 5.0%, dividend and buyback proposed.HUM
Q4 20242 Dec 2025 - Profitability and margins improved, supported by divestments and strong Norway growth.HUM
Q1 202528 Nov 2025 - Profitability up in Sweden and Norway; Finland transitions, with strong cash flow and lower debt.HUM
Q2 202516 Nov 2025